|
|
Other links at Articles > Allergy and Clinical Immunology |
| 1. |
Omalizumab Not Cost Effective for Severe Asthma
|
|
|
Omalizumab is not a cost-effective treatment for most patients with severe asthma, according to an analysis presented in the November Journal of Allergy and Clinical Immunology. Reuters Health Information
|
| 4. |
Congress Passes Genetic Privacy Bill
|
|
|
In this videoblog, Dr. Eric Topol updates us on some of the details and discusses what this might mean for the future if it is signed into law.
Medscape Pathology
|
|
|